Emphysema Recruiting Phase 2 Trials for Belimumab (DB08879)

Also known as: Bullous emphysema (lung)(pulmonary) / Pulmonary Emphysema / Emphysema pulmonary

IndicationStatusPhase
DBCOND0019688 (Emphysema)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03244059Belimumab Treatment of Emphysema Patients With Anti-GRP78 AutoantibodiesTreatment